The Amyloid β-Protein Precursor and Alzheimers Disease. Therapeutic Approaches
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
5
Page:
271-283
Author(s):
D. D. Toro, M. Coma, I. Uribesalgo, F. X. Guix and F. J. Munoz
The Neuroinflammatory Response in Plaques and Amyloid Angiopathy in Alzheimers Disease: Therapeutic Implications
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
4
Page:
223-233
Author(s):
Annemieke J.M. Rozemuller, Willem A van Gool and Piet Eikelenboom
Immunological Approaches to Prevent Neuronal Apoptosis During Neuroinflammation
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
4
Page:
367-381
Author(s):
F. J. Murphy, K. E. Keating, D. Sheehan and I. Hayes
Behçets Disease as an Autoinflammatory Disorder
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
4
Page:
81-83
Author(s):
Ahmet Gul
Strategies to Diminish the Ab Load in Alzheimers Disease
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
5
Page:
15-28
Author(s):
A. C. Cuello and K. F.S. Bell
Discovery, SAR and Medicinal Chemistry of Herpesvirus Helicase Primase Inhibitors
Journal:
Current Medicinal Chemistry - Anti-Infective Agents
Volume:
3
Page:
69-83
Author(s):
Gerald Kleymann
West Nile Virus Vaccine.
Journal:
Current Drug Targets - Infectious Disorders
Volume:
1
Page:
37-50
Author(s):
Thomas P. Monath, Juan Arroyo, Chuck Miller and Farshad Guirakhoo
The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
7
Page:
187-210
Author(s):
Andrea Abdipranoto, Sara Wu, Sandy Stayte and Bryce Vissel
Editorial [Hot Topic:Active and Passive Aβ-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part I (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
1-6
Author(s):
Michael G. Agadjanyan and David H. Cribbs
The Role of Microglia in Antibody-Mediated Clearance of Amyloid-Beta from the Brain
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
7-15
Author(s):
Dave Morgan